Slingshot members are tracking this event:
Aimmune (AIMT) Initiates Enrollment for Phase 3 PALISADE Trial Evaluating AR101 in Patients With Peanut Allergies
Slingshot Insights Explained
Jan 11, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Palisades Trial, Ar101, Peanut Allergies, Trial Initiation